2
Clinical Trials associated with CAR-NK Cells(The Second Hospital of Shandong University)Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors
To investigate the safety and efficacy of CAR-T/CAR-NK cells in patients with recurrent or unresectable solid tumors, including pancreatic cancer, prostate cancer, breast cancer, glioma, etc
Head of Hematology,Vice President and Secretary-General of Shandong Stem Cell Society
To investigate the safety and efficacy of CD19 CAR-T/CAR-NK cells in patients with relapsed/refractory B-cell lymphoma and acute B-lymphoblastic leukemia.
100 Clinical Results associated with CAR-NK Cells(The Second Hospital of Shandong University)
100 Translational Medicine associated with CAR-NK Cells(The Second Hospital of Shandong University)
100 Patents (Medical) associated with CAR-NK Cells(The Second Hospital of Shandong University)
100 Deals associated with CAR-NK Cells(The Second Hospital of Shandong University)